×
More Charts Below
Syra Health Net Income 2022-2024 | SYRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Recent Trends
Syra Health net income from 2022 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$35.1B
Tempus AI (TEM)
$7B
Hims & Hers Health (HIMS)
$6B
Inspire Medical Systems (INSP)
$4.5B
IRhythm Technologies (IRTC)
$3.2B
Privia Health (PRVA)
$2.9B
Schrodinger (SDGR)
$1.9B
Clover Health Investments (CLOV)
$1.8B
Enovis (ENOV)
$1.8B
Omnicell (OMCL)
$1.4B
Phreesia (PHR)
$1.4B
Azenta (AZTA)
$1.2B
10x Genomics (TXG)
$918M
Butterfly Network (BFLY)
$568M
Fulgent Genetics (FLGT)
$551M
Talkspace (TALK)
$450M
Veradigm (MDRX)
$449M
Standard BioTools (LAB)
$440M
TruBridge (TBRG)
$363M
Claritev (CTEV)
$325M
Health Catalyst (HCAT)
$270M
Nyxoah SA (NYXH)
$206M
SOPHiA GENETICS SA (SOPH)
$189M
Pulmonx (LUNG)
$182M
American Well (AMWL)
$109M
EUDA Health Holdings (EUDA)
$100M
Retrieve Medical Holdings (RMHI)
$82M
MDxHealth SA (MDXH)
$76M
P3 Health Partners (PIII)
$66M
111 (YI)
$64M